Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study
Chemotherapy · 2016 · 61 (6) · 281-286
DOI: 10.1159/000445045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemotherapy, online erschienen am 13.04.2016. Verfasst von Tarik Salman und 11 weiteren Autor:innen. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Several studies evaluating the prognostic factors of gastrointestinal and pancreatic neuroendocrine tumors (GEP-NETs) have been published. The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) have been accepted as prognostic factors for cancer patients. Materials and Methods: This study included 132 patients diagnosed with GEP-NETs. Peripheral blood samples were collected before the pretreatment period.
Results
NLR and PLR were increased as the grade increased in NETs. The embryonic origin analysis revealed higher NLR and PLR rates in NETs of foregut origin. NLR and PLR were also higher in pancreatic NET patients compared to the gastroenteric NET patients. Analysis of NETs by TNM indicated that an advanced stage was accompanied by significantly higher NLR and PLR. We found a strong negative correlation between progression-free survival and NLR and PLR.
Conclusion
The study verified that NLR and PLR are simple laboratory findings that can be used to identify NETs with a worse outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Salman, T., Kazaz, S. N., Varol, U., Oflazoglu, U., Unek, I. T., Kucukzeybek, Y., Alacacioglu, A., Atag, E., Semiz, H. S., Cengiz, H., Oztop, I., & Tarhan, M. O. (2016). Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. Chemotherapy, 61(6), 281-286. https://doi.org/10.1159/000445045
Vancouver
Salman T, Kazaz SN, Varol U, Oflazoglu U, Unek IT, Kucukzeybek Y, et al. Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study. Chemotherapy. 2016;61(6):281-286. doi:10.1159/000445045
BibTeX
@article{Salman2016,
author = {Salman, Tarik and Kazaz, Seher Nazli and Varol, Umut and Oflazoglu, Utku and Unek, Ilkay Tugba and Kucukzeybek, Yuksel and Alacacioglu, Ahmet and Atag, Elif and Semiz, Huseyin Salih and Cengiz, Hakan and Oztop, Ilhan and Tarhan, Mustafa Oktay},
title = {Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study},
journal = {Chemotherapy},
year = {2016},
volume = {61},
number = {6},
pages = {281--286},
doi = {10.1159/000445045}
}
EUVIMED